rs3910053 — NR3C2

NR3C2 rs3910053 — Salt Sensitivity Variant in the Mineralocorticoid Receptor Gene

The mineralocorticoid receptor¹¹ mineralocorticoid receptor
MR; the nuclear receptor for aldosterone and cortisol in the kidney sits at the heart of blood pressure regulation. When aldosterone binds MR in the distal nephron and collecting duct, the receptor translocates to the nucleus and upregulates the epithelial sodium channel (ENaC), driving sodium and water reabsorption. More sodium retained means a higher circulating volume and higher blood pressure. rs3910053 is an intronic variant within NR3C2 — the gene that encodes MR — that was identified in a controlled salt-loading study as a significant predictor of blood pressure elevation and long-term hypertension incidence.

The Mechanism

NR3C2 spans chromosome 4q31.1, a region rich in regulatory elements that control tissue-specific MR expression. rs3910053 sits approximately 11 kb deep in an intron, a position consistent with a regulatory role: intronic variants in nuclear receptor genes frequently fall within enhancer elements, splice-regulatory sequences, or binding sites for transcription factors that tune gene expression. The G allele at rs3910053 — the minor allele at ~25% global frequency — is the allele associated with elevated BP response to dietary sodium and with greater hypertension incidence over 14 years of follow-up. The most plausible mechanistic hypothesis is that the G allele increases MR expression or its aldosterone responsiveness in renal tubular cells, amplifying ENaC-mediated sodium reabsorption during high-salt conditions. This would explain the exaggerated blood pressure response to salt challenge seen in G carriers without requiring a change in the MR protein sequence.

The Evidence

The primary evidence for rs3910053 comes from Wang et al. 2025²² Wang et al. 2025
Associations of Genetic Variations in the NR3C2 With Salt Sensitivity, Longitudinal Blood Pressure Changes, and Incidence of Hypertension in Chinese Adults. J Clin Hypertens, 27(9):e70137, which studied 514 adults from 124 families in the GenSalt cohort through a controlled dietary sodium intervention (baseline → 3 g/day low-salt → 18 g/day high-salt phases) with 14 years of subsequent follow-up. rs3910053 showed significant negative correlations with systolic BP (SBP), diastolic BP (DBP), and mean arterial pressure (MAP) during the high-salt phase — meaning G allele carriers had greater blood pressure elevation under sodium loading — and was the NR3C2 variant most strongly associated with hypertension incidence across the follow-up period.

The broader NR3C2 locus has independent support. In the GenSalt replication dataset, He et al. 2015³³ He et al. 2015
Am J Hypertens 28:1310 found NR3C2 gene-based analysis significantly associated with longitudinal systolic BP change across 1,768 participants (P = 1×10⁻⁷), an association that replicated in Asian MESA participants (P = 1×10⁻⁴). Separately, the related NR3C2 variant rs5522 (I180V missense) has been shown to predict diastolic BP response to enalapril (Luo et al. 2014⁴⁴ Luo et al. 2014
Pharmacogenomics 15:201) and to associate with increased aldosterone levels and left ventricular hypertrophy in resistant hypertension (Ritter et al. 2016⁵⁵ Ritter et al. 2016
Am J Hypertens 29:245).

The limitation of the current evidence is that rs3910053's association derives from a single study in an East Asian cohort (n=514), without replication in independent cohorts or in non-Asian populations. The functional mechanism — how this intronic variant changes MR biology — has not been characterized. Evidence level is therefore emerging: single replication-grade study with a biologically coherent mechanism, but not yet replicated across independent populations.

Practical Actions

For carriers of one or two G alleles, the key intervention is dietary sodium control: the variant's effect is expressed specifically under high-salt conditions. Salt sensitivity means blood pressure rises more per gram of sodium consumed than in non-sensitive individuals, and research consistently shows that salt-sensitive individuals benefit more from sodium restriction than salt-resistant peers. Consistent monitoring of blood pressure — particularly during periods of higher sodium intake (travel, social events, restaurant meals) — provides early warning of MR-mediated volume expansion. For GG homozygotes, aldosterone-pathway medications (particularly MR antagonists such as spironolactone or eplerenone) are worth discussing with a physician if BP control is difficult, given the genetic evidence implicating MR overactivation.

Interactions

rs3910053 acts within the aldosterone–angiotensin axis alongside other blood pressure variants. The NR3C2 rs5522 I180V missense variant (in the ligand-binding domain) has been studied more extensively for drug response and cardiac outcomes — carriers of both rs3910053 G and rs5522 G are likely to have compounded MR-axis activation. The ENaC genes SCNN1B and SCNN1G (the downstream effectors of MR signaling) also carry common variants associated with BP in the same Tobin 2008 family study that found NR3C2 associations. Pathway interactions with ACE/ACE2, AGT, and AGTR1 variants are biologically expected in the salt-sensitivity phenotype and may compound the effect of rs3910053 on hypertension risk.